Jan Hendrik Schaefer Selected Research

Jan Hendrik Schaefer Research Topics

5	Stroke (Strokes) 01/2024 - 12/2019
3	Multiple Sclerosis 01/2023 - 01/2021
3	Inflammation (Inflammations) 04/2022 - 01/2021
3	Ischemic Stroke 01/2022 - 01/2020
2	Infarction (Infarctions) 02/2024 - 10/2023
2	Hemorrhage 12/2019 - 05/2014
2	Cerebral Hemorrhage 01/2019 - 05/2014
1	Deglutition Disorders (Dysphagia) 04/2024
1	Brain Infarction 10/2022
1	Neuroinflammatory Diseases 04/2022
1	Central Nervous System Diseases (CNS Diseases) 04/2022
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Cerebral Infarction 01/2020
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2019
1	Traumatic Brain Injuries (Traumatic Brain Injury) 05/2014

3	fibrin fragment D (D-dimer)IBA 04/2022 - 01/2022
2	GadoliniumIBA 01/2023 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2021
2	Prothrombin (Factor II)IBA 04/2022 - 05/2014
2	Fibrinogen (Factor I)FDA Link 04/2022 - 01/2022
2	Clopidogrel (Plavix)FDA Link 01/2020 - 12/2019
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 12/2019
2	AnticoagulantsIBA 01/2019 - 05/2014
1	Thrombin FDA Link 04/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	FibrinIBA 01/2022
1	C-Reactive ProteinIBA 01/2021
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2021
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2020
1	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2019
1	Dabigatran FDA Link 05/2014
1	Warfarin (Coumadin)FDA LinkGeneric 05/2014